Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological and Biochemical Biomarkers.

Zahraa Alkhazaali-Ali Sajad Sahab NegahAmir Reza BoroumandNajmeh Kaffash FarkhadMohammad Ali KhodadoustJalil Tavakol-Afshari

Published in: Diseases (Basel, Switzerland) (2024)

These results can indicate the potential benefit of stem cell transfusion in patients with ALS and suggest some diagnostic biomarkers. Several studies are required to approve these results.

Keyphrases

end stage renal disease
stem cells
ejection fraction
newly diagnosed
chronic kidney disease
mesenchymal stem cells
peritoneal dialysis
prognostic factors
cardiac surgery
acute kidney injury